The role of nitric oxide in the pathophysiology of intimal hyperplasia

Sadaf S. Ahanchi, Nick D. Tsihlis, Melina R. Kibbe*

*Corresponding author for this work

Research output: Contribution to journalArticle

90 Scopus citations

Abstract

Since its discovery, nitric oxide (NO) has emerged as a biologically important molecule and was even named Molecule of the Year by Science magazine in 1992. Specific to our interests, NO has been implicated in the regulation of vascular pathology. This review begins with a summary of the molecular biology of NO, from its discovery to the mechanisms of endogenous production. Next, we turn our attention to describing the arterial injury response of neointimal hyperplasia, and we review the role of NO in the pathophysiology of neointimal hyperplasia. Finally, we review the literature regarding NO-based therapies. This includes the development of inhalational-based NO therapies, systemically administered L-arginine and NO donors, NO synthase gene therapy, locally applied NO donors, and NO-releasing prosthetic materials. By reviewing the current literature, we emphasize the tremendous clinical potential that NO-based therapies can have on the development of neointimal hyperplasia.

Original languageEnglish (US)
Pages (from-to)A64-A73
JournalJournal of Vascular Surgery
Volume45
Issue number6 SUPPL.
DOIs
StatePublished - Jun 2007

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The role of nitric oxide in the pathophysiology of intimal hyperplasia'. Together they form a unique fingerprint.

  • Cite this